Literature DB >> 8380293

Investigation of the pathogenesis of varicella-zoster virus infection in guinea pigs by using polymerase chain reaction.

P W Lowry1, C Sabella, C M Koropchak, B N Watson, H M Thackray, G M Abbruzzi, A M Arvin.   

Abstract

The polymerase chain reaction method (PCR) was used to investigate events in the pathogenesis of varicella-zoster virus (VZV) infection in strain 2, Hartley, and euthymic hairless guinea pigs. VZV was detected in peripheral blood mononuclear cells (PBMC) obtained 2-5 days after infection in 8 (50%) of 16 strain 2, 4 (40%) of 10 hairless, and 10 (34%) of 29 Hartley guinea pigs. The frequency of VZV-infected PBMC was estimated to be at least 1/200,000, which is comparable to that observed in human infection. When VZV PCR was used to test ganglia from hairless guinea pigs, samples from 6 of 8 animals were positive. Of 45 VZV-infected guinea pigs that were tested for cellular immunity by VZV T lymphocyte proliferation assay, 44 developed a stimulation index > 2.0. Control animals had no detectable virus by PCR and did not develop cellular immunity to VZV. These experiments showed that viremia was detectable by PCR during primary VZV infection of guinea pigs in about half of the animals regardless of the strain of guinea pig. Acquisition of cellular immunity provided a consistent marker of infection in all guinea pig strains. PCR was also useful for demonstrating VZV in guinea pig ganglia tissue, with VZV gene sequences being detectable for at least 80 days after infection. With the combination of PCR and immunologic assays, various guinea pig strains should be useful for studies of VZV pathogenesis and for the evaluation of antiviral agents and vaccine strategies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380293     DOI: 10.1093/infdis/167.1.78

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization.

Authors:  James A Matriano; Michel Cormier; Juanita Johnson; Wendy A Young; Margaret Buttery; Kofi Nyam; Peter E Daddona
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

2.  Reactivation of Simian Varicella Virus in Rhesus Macaques after CD4 T Cell Depletion.

Authors:  Vicki Traina-Dorge; Brent E Palmer; Colin Coleman; Meredith Hunter; Amy Frieman; Anah Gilmore; Karen Altrock; Lara Doyle-Meyers; Maria A Nagel; Ravi Mahalingam
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

3.  Varicella-zoster virus open reading frame 2 encodes a membrane phosphoprotein that is dispensable for viral replication and for establishment of latency.

Authors:  Hitoshi Sato; Lesley Pesnicak; Jeffrey I Cohen
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 4.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

5.  Simian varicella virus pathogenesis.

Authors:  Ravi Mahalingam; Ilhem Messaoudi; Don Gilden
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 6.  VZV infection of keratinocytes: production of cell-free infectious virions in vivo.

Authors:  Michael D Gershon; Anne A Gershon
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  Clinical and molecular aspects of varicella zoster virus infection.

Authors:  Don Gilden; Maria A Nagel; Ravi Mahalingam; Niklaus H Mueller; Elizabeth A Brazeau; Subbiah Pugazhenthi; Randall J Cohrs
Journal:  Future Neurol       Date:  2009-01-01

8.  Immunization with the immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge.

Authors:  C Sabella; P W Lowry; G M Abbruzzi; C M Koropchak; P R Kinchington; M Sadegh-Zadeh; J Hay; W T Ruyechan; A M Arvin
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

Review 9.  Microneedle-based vaccines.

Authors:  Mark R Prausnitz; John A Mikszta; Michel Cormier; Alexander K Andrianov
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

10.  The DNA element controlling expression of the varicella-zoster virus open reading frame 28 and 29 genes consists of two divergent unidirectional promoters which have a common USF site.

Authors:  Min Yang; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.